Back to Stock Dashboard
Sector:
Financial Services
Add to portfolio
HQH
Abrdn Healthcare Investors
CAPPED RATING
Abrdn Healthcare Investors (HQH) is rated C- (2.1/5) on Deltasharpe Prism, scored against Financial Services sector peers. Its strongest pillar is Profitability (B); its weakest is Growth (F).
Quantitative Factor Evaluation • Updated
Overall Rating
2.1
/ 5.0
C-
Value
C-
Factor Score
1.9
/ 5.0
Growth
F
Factor Score
0.2
/ 5.0
Profitability
B
Factor Score
3.3
/ 5.0
Momentum
C
Factor Score
2.4
/ 5.0
Revisions
C+
Factor Score
2.5
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
4.9
EV / EBITDA
N/A
Rev Growth YoY
-42.1%
Gross Margin
N/M
Price Return 3M
-3.8%
Price Return 12M
38.9%
Catalyst Signal
0.00
Market Cap
$1.3B
TTM Revenue
$5.5M
Price / Sales
227.9
ROE
24.2%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-12 | C- (1.9) | F (0.2) | B (3.3) | C (2.4) | C+ (2.5) | C- (2.1) |
| 2026-11-05 | C- (1.9) | F (0.2) | B (3.3) | C+ (2.5) | C+ (2.6) | C- (2.1) |
| 2026-10-29 | C- (1.9) | F (0.1) | B (3.3) | B (3.2) | C+ (2.5) | C (2.2) |
| 2026-10-22 | C- (1.9) | F (0.2) | B (3.2) | B+ (3.5) | C+ (2.5) | C (2.3) |
| 2026-10-15 | C- (2.0) | F (0.2) | B (3.3) | B- (3.1) | C+ (2.5) | C (2.2) |
Page
1
of
4